RNA Q4 2021 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-13.5% YoY

Gross Profit

-$31M-1680.1% margin

Operating Income

-$39M-2081.4% margin

Net Income

-$39M-2080.9% margin

EPS (Diluted)

$-1.63

QoQ Revenue Growth

-14.4%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$28M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$428M

Total Liabilities

$46M

Stockholders' Equity

$381M

Cash & Equivalents

$320M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-13.5%
Gross Profit	-$31M	-$11M	-171.1%
Operating Income	-$39M	-$16M	-136.6%
Net Income	-$39M	-$16M	-136.8%